Yuyin Xu

976 total citations
26 papers, 721 citations indexed

About

Yuyin Xu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yuyin Xu has authored 26 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Yuyin Xu's work include Lung Cancer Treatments and Mutations (5 papers), RNA Interference and Gene Delivery (4 papers) and Immune Response and Inflammation (3 papers). Yuyin Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), RNA Interference and Gene Delivery (4 papers) and Immune Response and Inflammation (3 papers). Yuyin Xu collaborates with scholars based in China. Yuyin Xu's co-authors include Weijia Li, Jing Zhou, Jing Qin, Guilan Wang, Li Chen, Song He, Xiaolei Cao, Yixin Zhang, Xiaolan Chen and Xingyu Li and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Yuyin Xu

23 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyin Xu China 11 194 134 130 102 93 26 721
Chongyang Wang China 17 273 1.4× 106 0.8× 137 1.1× 156 1.5× 72 0.8× 64 853
Xiaofeng Ding China 16 288 1.5× 259 1.9× 116 0.9× 82 0.8× 137 1.5× 37 900
Lingjie Li China 14 242 1.2× 197 1.5× 85 0.7× 75 0.7× 83 0.9× 44 871
Shemin Lu China 17 285 1.5× 151 1.1× 94 0.7× 155 1.5× 42 0.5× 39 872
Zhenyu Yao China 16 231 1.2× 261 1.9× 80 0.6× 96 0.9× 140 1.5× 34 773
Tianyi Wang China 13 123 0.6× 68 0.5× 81 0.6× 110 1.1× 84 0.9× 34 685
Yi Liang China 18 382 2.0× 181 1.4× 65 0.5× 80 0.8× 126 1.4× 55 935
Rui Deng China 12 177 0.9× 92 0.7× 140 1.1× 50 0.5× 152 1.6× 33 826
Zhenzhen Zhang China 15 228 1.2× 62 0.5× 70 0.5× 68 0.7× 63 0.7× 35 696
Xiaorong Zhang China 19 214 1.1× 140 1.0× 67 0.5× 166 1.6× 164 1.8× 54 995

Countries citing papers authored by Yuyin Xu

Since Specialization
Citations

This map shows the geographic impact of Yuyin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyin Xu more than expected).

Fields of papers citing papers by Yuyin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyin Xu. The network helps show where Yuyin Xu may publish in the future.

Co-authorship network of co-authors of Yuyin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyin Xu. A scholar is included among the top collaborators of Yuyin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyin Xu. Yuyin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Yuyin, Ling Zhang, Min Ren, et al.. (2024). Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer. Journal of Thoracic Disease. 16(1). 40–50. 2 indexed citations
3.
Xu, Feng, Qianlan Yao, Yuyin Xu, et al.. (2024). Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma. International Journal of Cancer. 155(10). 1780–1791.
4.
Yu, Changmin, Xin‐hui Yuan, Qianlan Yao, et al.. (2024). Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort. BMC Cancer. 24(1). 862–862. 5 indexed citations
5.
Chu, Xiao, Yuyin Xu, Li Ye, et al.. (2022). Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon. Lung Cancer. 169. 22–30. 11 indexed citations
6.
Zhang, Jing, Xin Zhang, Qian Wang, et al.. (2022). Histomorphological and molecular genetic characterization of different intratumoral regions and matched metastatic lymph nodes of colorectal cancer with heterogenous mismatch repair protein expression. Journal of Cancer Research and Clinical Oncology. 149(7). 3423–3434. 4 indexed citations
7.
Su, Yifan, Qianlan Yao, Yuyin Xu, et al.. (2021). Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in Genetics. 12. 674094–674094. 13 indexed citations
8.
Li, Fang, Chenyang Qi, Xing Mao, et al.. (2020). Plakoglobin is involved in cytoskeletal rearrangement of podocytes under the regulation of UCH-L1. Biochemical and Biophysical Research Communications. 529(1). 112–118. 7 indexed citations
9.
Zhang, Xin, Yuyin Xu, Qianming Bai, et al.. (2020). Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 319(1). G87–G96. 8 indexed citations
10.
Xu, Yuyin, Lijing Wu, Xin Zhang, et al.. (2020). High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma. Experimental and Molecular Pathology. 117. 104548–104548. 13 indexed citations
11.
Xu, Yuyin, Hongyang Gao, Yuan Hu, et al.. (2019). High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway. Experimental Cell Research. 382(2). 111463–111463. 54 indexed citations
12.
Wang, Ting, Mingsan Miao, Ming Bai, et al.. (2017). Effect of sophora japonica total flavonoids on pancreas, kidney tissue morphology of streptozotocin-induced diabetic mice model. Saudi Journal of Biological Sciences. 24(3). 741–747. 24 indexed citations
13.
Zhao, Xiaolei, et al.. (2016). Detection of ALK gene rearrangement in non-small cell lung cancer. 43(5). 340–342.
14.
Ji, Fen, Xia Jiang, Yuyin Xu, et al.. (2016). Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases. Journal of Clinical Laboratory Analysis. 31(5). e22074–e22074. 16 indexed citations
15.
Li, Weijia, Jing Zhou, & Yuyin Xu. (2015). Study of the in vitro cytotoxicity testing of medical devices. Biomedical Reports. 3(5). 617–620. 327 indexed citations
16.
Xu, Yuyin, et al.. (2015). Role of the ER stress in prostaglandin E2/E-prostanoid 2 receptor involved TGF-β1-induced mice mesangial cell injury. Molecular and Cellular Biochemistry. 411(1-2). 43–55. 9 indexed citations
17.
Xu, Yuyin, et al.. (2014). A Maladaptive Role for EP4 Receptors in Mouse Mesangial Cells. PLoS ONE. 9(8). e104091–e104091. 10 indexed citations
18.
Wang, Guilan, Li Chen, Yuyin Xu, et al.. (2014). The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. BMC Cancer. 14(1). 327–327. 101 indexed citations
19.
Xu, Yuyin, Li Chen, Jiaming Zhou, Yuanyuan Wu, & Yuanyuan Zhu. (2013). Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model. Molecular Medicine Reports. 8(4). 1037–1042. 16 indexed citations
20.
Qin, Jing, Yuyin Xu, Xingyu Li, et al.. (2013). Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. Experimental and Molecular Pathology. 96(1). 1–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026